Literature DB >> 590850

Platelet function in fulminant hepatic failure and effect of charcoal haemoperfusion.

M J Weston, P G Langley, M H Rubin, M A Hanid, P Mellon, R Williams.   

Abstract

In 34 patients with fulminant hepatic failure, platelets, in addition to being reduced in numbers, were smaller than those of healthy controls. In keeping with this, capillary bleeding times were significantly longer than could be accounted for by reduction in numbers alone. In a small group of these patients use of charcoal haemoperfusion for temporary liver support produced a doubling of the capillary bleeding time despite only a small drop in arterial platelet counts. This disproportionate prolongation of bleeding time was almost certainly caused by the loss of larger platelets in the charcoal columns during perfusion, as the mean median volume also fell during perfusion. Rises in screen filtration pressure of blood leaving the columns were found during some perfusions and thought to be indicative of platelet aggregates. Release of vasoactive substances from platelets could account for the hypotension often found at this time.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 590850      PMCID: PMC1411729          DOI: 10.1136/gut.18.11.897

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  The mechanism of the prolonged bleeding time provoked by dextran sulphate or by excessive doses of heparin.

Authors:  C F BORCHGREVINK
Journal:  Acta Med Scand       Date:  1961-09

2.  Morphology and enumeration of human blood platelets.

Authors:  G BRECHER; E P CRONKITE
Journal:  J Appl Physiol       Date:  1950-12       Impact factor: 3.531

3.  Charcoal haemoperfusion in the treatment of fulminant hepatic failure.

Authors:  B G Gazzard; M J Weston; I M Murray-Lyon; H Flax; C O Record; R Williams; B Portmann; P G Langley; E H Dunlop; P J Mellon; M B Ward
Journal:  Lancet       Date:  1974-06-29       Impact factor: 79.321

4.  Intravascular coagulation in acute hepatic necrosis.

Authors:  M O Rake; P T Flute; G Pannell; R Williams
Journal:  Lancet       Date:  1970-03-14       Impact factor: 79.321

5.  The bleeding time as a screening test for evaluation of platelet function.

Authors:  L A Harker; S J Slichter
Journal:  N Engl J Med       Date:  1972-07-27       Impact factor: 91.245

6.  The importance of microembolism in the pathogenesis of organ dysfunction caused by prolonged use of the pump oxygenator.

Authors:  D B Allardyce; S H Yoshida; P G Ashmore
Journal:  J Thorac Cardiovasc Surg       Date:  1966-11       Impact factor: 5.209

7.  The hemostatic mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation.

Authors:  R McKenna; F Bachmann; B Whittaker; J R Gilson; M Weinberg
Journal:  J Thorac Cardiovasc Surg       Date:  1975-08       Impact factor: 5.209

8.  Platelet function in dialyzed and non-dialyzed patients with chronic renal failure.

Authors:  R M Lindsay; A V Moorthy; F Koens; A L Linton
Journal:  Clin Nephrol       Date:  1975-08       Impact factor: 0.975

9.  Use of charcoal haemoperfusion in the management of severely poisoned patients.

Authors:  J A Vale; A J Rees; B Widdop; R Goulding
Journal:  Br Med J       Date:  1975-01-04

10.  A rapid method for assessing megathrombocytes: its application to thrombocytotic and acquired thrombocytopenic states.

Authors:  F A Hunt
Journal:  Pathology       Date:  1976-01       Impact factor: 5.306

View more
  6 in total

Review 1.  Trials and tribulations with artificial liver support.

Authors:  R Williams
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

2.  Comment on the editorial "Prostacylin (PGI2)".

Authors:  M T Weston
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

3.  Progress in the management of fulminant hepatic failure.

Authors:  S Braude; A E Gimson; R Williams
Journal:  Intensive Care Med       Date:  1981-04       Impact factor: 17.440

Review 4.  Platelets in liver and renal disease.

Authors:  Michele P Lambert
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

5.  Activated charcoal haemoperfusion via an extracorporeal circuit in the unrestrained and unanaesthetized rat.

Authors:  C J Ryan; J M Courtney; C B Wood; R G Hood; L H Blumgart
Journal:  Br J Exp Pathol       Date:  1979-08

Review 6.  Targeting von Willebrand factor in liver diseases: A novel therapeutic strategy?

Authors:  Dafna J Groeneveld; Lauren G Poole; James P Luyendyk
Journal:  J Thromb Haemost       Date:  2021-05-03       Impact factor: 16.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.